Life Sciences

Meest recente

1 naar 10 van 633
  • La télémédecine en Belgique: état des lieux

    Artikel

    Ingediend: 21 September 2017

    À l’heure où les nouvelles technologies se développent pour permettre aux patients d’accéder à des services de santé individualisés depuis le confort de leur maison, la pratique de la télémédecine continue de soulever de nombreuses questions.

  • Ontbijtseminar Actualiteiten Ondernemingsrecht

    Seminar

    Datum: 27 September 2017

    Tijdens deze bijeenkomst wordt ingegaan op enkele recente ontwikkelingen binnen het ondernemingsrecht relevant voor de ondernemingsrechtelijke praktijk, waaronder die van de fusies en overnames. Aan bod komen onder andere de rol van bestuurders en commissarissen en aansprakelijkheden. Bij de bespreking van een en ander passeren ook actuele ervaringen uit de praktijk de revue.

  • Case summary: Secretary of State for Health v Servier Laboratories Limited

    Artikel

    Ingediend: 19 September 2017

    If a patentee makes unsupported allegations in enforcement or invalidity proceedings which result in losses to third parties, can that amount to the tort of causing loss by unlawful means?

  • Brexit & MedTech

    Blog Post

    Ingediend: 19 September 2017

    In our latest blog post, we look at the ABHI’s Brexit Seminar which we hosted on “Politics, Policy, Business and Brexit - what next for MedTech?” where we discussed the key commercial and regulatory implications of Brexit for the MedTech sector.

  • The Sunshine Act & the General Data Protection Regulation: compliance training

    Conferentie

    Ingediend: 14 September 2017

    This training was provided at the Sunshine Act Info Session held by the Belgian non-profit organisation Mdeon on 12 September 2017. The full slide-deck of the Info Session may be viewed on www.betransparent.be.

  • An innovative merge clearance decision in the healthcare institutions’ sector

    Artikel

    Ingediend: 11 September 2017

    The French Competition Authority (FCA) has adopted an innovative merger decision in the health care institution sector, assessing not only the effects of the operation on medical services (diagnostic and treatments), but also the effects on non-medical ancillary services.

  • EU sets out its position on IP rights post Brexit

    Artikel

    Ingediend: 11 September 2017

    The European Commission has published a five page position paper setting out the main principles of its position on intellectual property rights in the Article 50 Brexit negotiations with the UK.

  • Les 5 Ordonnances Macron dévoilées: Une réforme majeure du droit du travail en France

    Artikel

    Ingediend: 04 September 2017

    En 36 mesures, ces Ordonnances vont opérer une profonde rénovation du dialogue social, une sécurisation du coût des licenciements et une simplification des licenciements économiques.

  • SPCs for new formulations?

    Artikel

    Ingediend: 04 September 2017

    An update on the UK Supplementary Protection Certificates (SPC) referral in Abraxis which is progressing towards the Court of Justice of the European Union (CJEU). The UK Intellectual Property Office (IPO) is now asking for comments on this significant case concerning the interpretation of Article 3(d) of the SPC Regulation.

  • CETA to boost M&A

    Artikel

    Ingediend: 04 September 2017

    The Canada-European Union Comprehensive Economic Trade Agreement (CETA) will come into preliminary effect on 21 September 2017. CETA will eliminate 98% of the EU tariffs.

1 naar 10 van 633